<DOC>
	<DOCNO>NCT02440815</DOCNO>
	<brief_summary>The specific focus study gather data regard effect psychological therapy know Problem Solving Therapy ( PST ) cerebral blood flow ( CBF ) , cortical gray matter ( GM ) atrophy , subcortical white matter ( WM ) lesion burden , measure cognitive function subject Late Life Major Depressive Disorder ( LLD ) . This research goal achieve recruit 110 individual age 65 LLD . The primary outcome change CBF , change GM atrophy , change WM lesion , change cognitive function , change depression severity baseline end 12 week PST .</brief_summary>
	<brief_title>Multimodal MRI Characteristics Psychotherapy Response Late Life Depression</brief_title>
	<detailed_description>Study procedure include : 1 ) Telephone screen , 2 ) Diagnostic evaluation determine diagnosis MDD , 3 ) Baseline evaluation consist medical history , cognitive assessment , MRIs , 4 ) Participation 12 week psychotherapy treatment assessment depression severity , 5 ) Follow evaluation 12 week consist depression , cognitive function , post treatment MRIs . Telephone Screen : Older adult respond recruitment effort LLD screen telephone use Patient Health Questionnaire ( PHQ-9 ) obtain score 5 great schedule eligibility appointment within week screening . Anyone endorse suicide question ( item 9 ) PHQ-9 schedule day appointment , see study investigator . Similarly , exclusion criterion assess use structure questionnaire . If participant interested treatment referral provide . Diagnostic Evaluation : In assessment , investigator consent participant administer measure address eligibility [ i.e. , Structured Clinical Interview Diagnosis DSM-IV Disorders ( SCID ) ] , 24 item HDRS , Mini Mental Status Exam ( MMSE ) , Clinical Dementia Rating Scale ( CDR ) . To qualify , LLD participant must obtain diagnosis MDD ( SCID ) , HDRS score 20 high , MMSE score 25 good , CDR 0.5 less.. Those qualify study and/or interested alternate LLD treatment offer referral service outpatient clinic UCSF community resource . Baseline Assessment : After completion diagnostic evaluation deem study eligible , LLD participant schedule baseline assessment . At baseline assessment meeting , HDRS administer confirm depression severity . The baseline assessment consist 1 ) demographic patient characteristic , 2 ) neuropsychological testing , 3 ) depression functional outcome measure , 4 ) multimodal MRI evaluation . Participant Characteristics : Demographic data , age , gender , race , live condition , marital status , occupation , education obtain well previous psychiatric treatment receive . Medical comorbidity assess use Charlson Comorbidity Index ( CCI ) . Medication use assess use Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) medication history form . Suicidal ideation assess utilizing Scale Suicidal Ideation ( SSI ) . The investigator utilize clinician rat measure lifetime history depressive episode depression treatment , Duke Social Support Index , Functional Activities Questionnaire ( FAQ ) exploratory analysis . Cognitive Functioning : Primary cognitive outcome variable include : Digit Symbol Substitution Test , Boston Naming test , Rey Auditory Verbal Learning Test measure memory . Psychotherapeutic Treatment : Problem Solving Therapy ( PST ) brief evidence base psychotherapy commonly utilized treatment LLD . The problem solve therapy include 12 weekly person 50 minute session . Follow assessment : At 12 week , LLD participant participate follow evaluation identical baseline assessment depression , cognitive function , MRI . The investigator use total HDRS score determine response treatment .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>1 . Current DSMIV diagnosis MDD , unipolar type , without psychotic feature 6 week minimum duration current depressive episode . 2 . Moderate severity depression use Hamilton Depression Rating Scale ( HDRS &gt; 20 ) . 3 . English speaking , male female 4 . 65 year age old 5 . Good general health 6 . Able give inform consent 1 . Antidepressant use psychotherapy within past 6 week electroconvulsive therapy within past 6 month . 2 . Recent history ( &lt; 6 month ) substance alcohol abuse dependence ( DSMIV criterion ) . 3 . Use cognitive enhancing medication . 4 . Current diagnosis PostTraumatic Stress Disorder Axis 1 psychiatric disorder . 5 . Neurological disease ( e.g. , Parkinson 's disease , epilepsy , cortical stroke , Alzheimer 's disease , traumatic brain injury ) dementia . 6 . History surgical procedure affect study outcome . 7 . Contraindications MR exam , i.e. , claustrophobia , paramagnetic metal implant , able fit MRI machine comfortably ( BMI â‰¤ 38 ) . 8 . Acute uncontrolled medical illness medication use impact cognitive function .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Psychotherapy</keyword>
	<keyword>Problem Solving Therapy ( PST )</keyword>
	<keyword>Depression</keyword>
	<keyword>Major Depression</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Late Life Depression</keyword>
	<keyword>Multimodal imaging</keyword>
	<keyword>Magnetic Resonance Imaging ( MRI )</keyword>
	<keyword>Cerebral blood flow</keyword>
	<keyword>Cortical atrophy</keyword>
	<keyword>White matter lesion</keyword>
</DOC>